SCHEMBL31513494

SCHEMBL31513494

O=c1[nH]nc(OC2(F)CC2)c2cc(Br)ccc12

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ PRMT5 O14744 2/20 0.38
▸ WDR77 Q9BQA1 2/20 0.38
▸ ALDH1A1 P00352 2/20 0.35
▸ L3MBTL1 Q9Y468 1/20 0.35
▸ JAK2 O60674 3/20 0.33
▸ CHEK1 O14757 3/20 0.33
▸ DYRK1A Q13627 3/20 0.33
▸ PIM1 P11309 2/20 0.33
▸ FLT3 P36888 2/20 0.33
▸ METAP2 P50579 1/20 0.33
▸ AURKA O14965 1/20 0.33
▸ DAPK3 O43293 1/20 0.33
▸ PRKD3 O94806 1/20 0.33
▸ MAP4K4 O95819 1/20 0.33
▸ PAK4 O96013 1/20 0.33
▸ ABL1 P00519 1/20 0.33
▸ NTRK1 P04629 1/20 0.33
▸ CSF1R P07333 1/20 0.33
▸ RET P07949 1/20 0.33
▸ MET P08581 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25431065 0.79 PRMT5 (0.37) PRMT5WDR77ALDH1A1L3MBTL1JAK2
SCHEMBL30579879 0.79 PRMT5 (0.37) PRMT5WDR77ALDH1A1L3MBTL1JAK2
SCHEMBL30451904 0.76 PRMT5 (0.40) PRMT5WDR77ALDH1A1L3MBTL1JAK2
SCHEMBL26732890 0.76 PRMT5 (0.43) PRMT5WDR77ALDH1A1L3MBTL1JAK2
SCHEMBL26732994 0.76 PRMT5 (0.40) PRMT5WDR77ALDH1A1L3MBTL1JAK2
SCHEMBL26049203 0.75 PRMT5 (0.38) PRMT5WDR77ALDH1A1L3MBTL1JAK2
SCHEMBL26049201 0.75 PRMT5 (0.38) PRMT5WDR77ALDH1A1L3MBTL1JAK2
SCHEMBL20944947 0.72 PRMT5 (0.40) PRMT5WDR77ALDH1A1L3MBTL1JAK2
SCHEMBL23914628 0.71 PRMT5 (0.46) PRMT5WDR77ALDH1A1L3MBTL1JAK2
SCHEMBL29735211 0.71 PRMT5 (0.46) PRMT5WDR77ALDH1A1L3MBTL1JAK2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250145592-A1 COMPOUNDS, COMPOSITIONS, AND METHODS TENVIE THERAPEUTICS, INC. 2025-05-08 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20250145592-A1 COMPOUNDS, COMPOSITIONS, AND METHODS NLRP3, NLRP1, NOD1 PRMT5 2627/4885WDR77 2143/4885ALDH1A1 4174/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback